1. Home
  2. SPT vs TMDX Comparison

SPT vs TMDX Comparison

Compare SPT & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPT
  • TMDX
  • Stock Information
  • Founded
  • SPT 2010
  • TMDX 1998
  • Country
  • SPT United States
  • TMDX United States
  • Employees
  • SPT N/A
  • TMDX N/A
  • Industry
  • SPT Computer Software: Prepackaged Software
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • SPT Technology
  • TMDX Health Care
  • Exchange
  • SPT Nasdaq
  • TMDX Nasdaq
  • Market Cap
  • SPT 1.9B
  • TMDX 2.3B
  • IPO Year
  • SPT 2019
  • TMDX 2019
  • Fundamental
  • Price
  • SPT $22.00
  • TMDX $68.27
  • Analyst Decision
  • SPT Buy
  • TMDX Buy
  • Analyst Count
  • SPT 15
  • TMDX 10
  • Target Price
  • SPT $33.85
  • TMDX $118.44
  • AVG Volume (30 Days)
  • SPT 693.7K
  • TMDX 796.2K
  • Earning Date
  • SPT 05-01-2025
  • TMDX 04-29-2025
  • Dividend Yield
  • SPT N/A
  • TMDX N/A
  • EPS Growth
  • SPT N/A
  • TMDX N/A
  • EPS
  • SPT N/A
  • TMDX 1.01
  • Revenue
  • SPT $405,908,000.00
  • TMDX $441,540,000.00
  • Revenue This Year
  • SPT $12.30
  • TMDX $25.24
  • Revenue Next Year
  • SPT $13.09
  • TMDX $19.89
  • P/E Ratio
  • SPT N/A
  • TMDX $67.59
  • Revenue Growth
  • SPT 21.66
  • TMDX 82.74
  • 52 Week Low
  • SPT $21.51
  • TMDX $55.00
  • 52 Week High
  • SPT $59.04
  • TMDX $177.37
  • Technical
  • Relative Strength Index (RSI)
  • SPT 23.78
  • TMDX 47.68
  • Support Level
  • SPT $21.51
  • TMDX $65.90
  • Resistance Level
  • SPT $25.81
  • TMDX $73.68
  • Average True Range (ATR)
  • SPT 0.91
  • TMDX 3.34
  • MACD
  • SPT -0.06
  • TMDX -0.05
  • Stochastic Oscillator
  • SPT 11.40
  • TMDX 51.08

About SPT Sprout Social Inc

Sprout Social Inc develops a cloud software that brings together social messaging, data and workflows in a unified system of record, intelligence, and action. The firm generates majority revenue from software subscriptions.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: